Abstract
The prevalence of ADHD in adolescence ranges from 4 to 6%. In this age range, the disorder may manifest in difficulty fulfilling academic, personal and social responsibilities. Adolescents with ADHD often struggle to maintain routines, organize their time, be effective interpersonally, inhibit stimulus-seeking behaviors, and control their emotional reactions. Around 75% of adolescents with ADHD have at least one comorbid disorder. The most frequent are Conduct Disorder (15–30%), Substance Abuse Disorder (30–70% depending on the drug), and Mood or Anxiety Disorders (20–40%). The presence and severity of these disorders leads to under-diagnosis of ADHD, and management of ADHD may prevent or reduce morbidity associated with comorbid conditions. Collection of data by interview is sufficient to identify a diagnosis of ADHD across the lifespan. Neuropsychological evaluation may be critical to confirm learning disabilities and need for possible learning accommodation in this age group. Academic supports and accommodations may be helpful both in straightforward ADHD and in the presence of other learning disabilities. Severe outcomes associated with ADHD can occur in this age range, including illegal behavior, risky sexual activities or motor accidents. Psychopharmacology improves ADHD in adolescents and is clinically observed to reduce many but not all of these poor outcomes. It is useful to look for risk factors of worse prognosis and to anticipate persistence into adult life to design a specific support and treatment plan.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Biederman J, Milberger S, Faraone SV. Age dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157:816–8.
Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111:279–89.
Biederman J, Faraone S, Millberger S, Gershon J, Tsuang MT. A prospective 4-year follow-up study of attention-deficit hyperactivity disorder. Arch Gen Psychiatr. 1996;53(5):437–46.
American Psychiatric Association. Diagnostic and statistical manual of mental disorder. 4th ed (DSM-IV-TR). Washington: APA; 2000.
Wasserstein J. Diagnostic issues for adolescents and adults with ADHD. JCLP/In Session. 2005;61(5):535–47.
Biederman J, Monuteaux MC, Doyle AE, et al. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol. 2004;72(5):757–66.
Taurines R, Schmit J, Renner T, Conner AC, Warnke A, Romanos M. Developmental comorbidity in attention-deficit/hyperactivity disorder. Atten Defic Hyperact Disord. 2010;2(4):267–89.
Klassen LJ, Katzman MA, Chokka P. Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord. 2010;124:1–8.
Soutullo CA, Escamilla I, Wozniak J, Gamazo P, Figueroa A, Biederamn J. Phenomenology of pediatric bipolar disorder in a Spanish sample: features before and at the moment of diagnosis. J Affect Disord. 2009;118(1–3):39–47.
Escamilla I, Wozniak J, Soutullo CA, Gamazo-Garrán P, Figueroa-Qintana A, Biederman J. Pediatric bipolar disorder in a Spanish sample: results after 2.6 years of follow-up. J Affect Disord. 2011;132(1–2):270–4.
Pavuluri MN, Biramher B, Naylor MW. Pediatric bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2005;44(9):846–71.
Kowatch RA, Delbello MP. Pediatric bipolar disorder: emerging diagnostic and treatment approaches. Child Adolesc Psychiatr Clin N Am. 2006;15(1):73–108.
Biederman J, Petty CR, Byrne D, Wong P, Wozniak J, Faraone SV. Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study. J Affect Disord. 2009;119(1–3):16–21.
Palazzo B, Moreira de Sousa C, Coutinho G, et al. Review of literature of attention-deficit/hyperactivity disorder with comorbid eating disorder. Rev Bras Psiquiatr. 2008;30(4):384–9.
Surman CB, Randall ET, Biederman J. Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case–control studies. J Clin Psychiatry. 2006;67(3):351–4.
Cortese S, Isnard P, Frelut ML, et al. Association between symptoms of attention-deficit/hyperactivity disorder and bulimic behaviors in a clinical sample of severely obese adolescents. Int J Obes. 2007;31(2):340–6.
Biederman J, Ball SW, Monuteaux MC, Surman CB, Johnson JL, Zeitlin S. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr. 2007;28(4):302–7.
Mikami AY, Hinshaw SP, Patterson KA, Lee JC. Eating pathology among adolescent girls with attention-deficit/hyperactivity disorder. J Abnorm Psychol. 2008;117(1):225–35.
Agranat Meged AN, Deitcher C, Goldzwig G, Leibenson L, Stein M, Galili-Wisstub E. Childhood obesity and attention deficit/hyperactivity disorder: a newly described comorbidity in obeses hospitalized children. Int J Eat Disord. 2005;37(4):357–9.
Konofal E, Lecendreux M, Cortese S. Sleep and ADHD. Sleep Med. 2010;11:652–8.
Cortese S, Konofal E, Yateman N, et al. Sleep and alertness in children with attention-defict hyperactivity disorder: a systematic review of the literature. Sleep Med. 2005;29(4):504–11.
Konofal E, Cortese S, Marchand M, Mouren MC, Arnulf I, Lecendreux M. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med. 2007;8:711–5.
Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D. Effects of atomexetine and methylphenidate on sleep in children with ADHD. Sleep. 2006;29:1573–85.
Van der Heijden KB, Smits MG. Van Someren Ej. Gunning WB. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol Int. 2005;22:559–70.
Bendz LM, Scates AC. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother. 2010;44(1):185–91.
Biederman J, Petty CR, Dolan C, Hughes S, et al. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med. 2008;38:1027–36.
Willens TE, Morrison NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry. 2011;24(4):280–5.
Flory K, Milich R, Lynam DR, Leukefeld C, Clayton R. Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms in young adulthood: individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk. Psychol Addict Behav. 2003;17(2):151–8.
Wilens TE, Adler LA, Adams J, et al. Misuse and diversión of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31.
Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2):e20.
Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;11:179–85.
Miller CJ, Flory JD, Miller SR, Harty SC, Newcorn JH, Halperin JM. Childhood ADHD and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry. 2008;69(9):1477–84.
Phillipsen A, Limberger MF, Lieb K, et al. Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry. 2008;192:118–23.
Fischer M, Barkley RA, Samallish L, Fletcher K. Young adult follow-up of hyperactive children: self-reported psychiatry disorders, comorbidity, and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol. 2002;30:463–75.
Dijk FE, Lappenschaar M, Kan CC, Verkes R, Buitelaar JK. Symptomatic overlap between attention-deficit/hyperactivity disorder and borderline personality disorder in women: the role of temperament and character traits. Compr Psychiatry. 2012;53(1):39–47. doi:10.1016/j.comppsych.2011.02.007.
Golubchik P, Server J, Zalsman F, Weizman A. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Int Clin Psychopharmacol. 2008;23(4):228–31.
Biederman J, Petty C, Clarke A, Lomedico A, Faraone SV. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res. 2011;45:150–5.
Green RW, Ablon SJ. Treating explosive kids. New York: Guildford; 2006.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Escamilla, I. (2013). Managing ADHD in Adolescence and Young Adulthood: Emerging Comorbidities and Tailored Treatment. In: Surman, C. (eds) ADHD in Adults. Current Clinical Psychiatry. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-248-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-248-3_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-247-6
Online ISBN: 978-1-62703-248-3
eBook Packages: MedicineMedicine (R0)